Clinical trial
A Study Of BOTOX For The Treatment Of Glabellar Lines
NCT00408785 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00408785 |
|---|---|
| Title | A Study Of BOTOX For The Treatment Of Glabellar Lines |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of BOTOX? (Botulinum Toxin Type A) in Subjects With Glabellar Lines |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glabellar Lines |
| Intervention type | Drug |
| Interventions | Botulinum Toxin Type A, sodium chloride |
| Enrollment | 256 |
| Start date | Nov 1, 2006 |
| Primary completion | May 9, 2007 |
| Completion | May 9, 2007 |
| First posted | Dec 7, 2006 |
| Last update posted | May 31, 2017 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: